Clinical significance of up-regulated miR-181a in prognosis and progression of esophageal cancer

Acta Biochim Biophys Sin (Shanghai). 2014 Nov;46(11):1007-10. doi: 10.1093/abbs/gmu083. Epub 2014 Sep 17.

Authors

Zhengkai Xiang¹, Xiaochuan Dong², Qianqiang Sun¹, Xiang Li³, Baoguo Yan⁴

Affiliations

¹ Department of Thoracic and Bone-soft tissue Surgery, Hubei Cancer Hospital, Wuhan 430000, China.
² Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
³ Department of Orthopedics, the First People's Hospital of Taizhou, Taizhou 318020, China.
⁴ Department of Thoracic and Bone-soft tissue Surgery, Hubei Cancer Hospital, Wuhan 430000, China baoguoy718@163.com.

PMID: 25230784
DOI: 10.1093/abbs/gmu083

No abstract available

MeSH terms

Biomarkers, Tumor / genetics
Biomarkers, Tumor / metabolism
Cell Line, Tumor
Cell Proliferation
Disease Progression
Disease-Free Survival
Esophageal Neoplasms / genetics*
Esophageal Neoplasms / metabolism*
Esophageal Neoplasms / pathology
Female
Humans
Kaplan-Meier Estimate
Male
MicroRNAs / genetics*
MicroRNAs / metabolism*
Middle Aged
Prognosis
Retrospective Studies
Up-Regulation

Substances

Biomarkers, Tumor
MIrn181 microRNA, human
MicroRNAs